# Acadia Healthcare Company Inc. (ACHC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $28.13, market value $2.6 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Acadia Healthcare Company Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.8×**. Each dollar of revenue is priced at 0.8×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -5.1%** (5-yr avg -9.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Net margin: -33.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -56.6%**. Return on equity is negative because earnings are negative.
- **Return on assets: -20.4%**. Each dollar of assets produces -20.4% of profit.

## Growth
- **Revenue growth (1 yr): 5.0%** (3-yr 8.3%/yr, 5-yr 9.7%/yr). Revenue grew 5.0% over the last year, against 9.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -537.4%**. Earnings per share fell 537.4%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 1.28**. Debt is 1.28 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Acadia Healthcare Company Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (14 analysts). 14 analysts cover Acadia Healthcare Company Inc.; the consensus is buy, with an average price target of $33.39 (+19% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 18.9%** (YTD 98.2%, 3-mo 14.9%). The shares are up 18.9% over twelve months including dividends.
- **From 52-week high: -21.5%** (146.1% above the low). Trading 21% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 0.89** (volatility 67%). Beta of 0.89 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ACHC · Page: https://foliofundamentals.com/stocks/achc

Not investment advice.